TheraRadar

Johnson & Johnson

158 active trials across 14 therapeutic areas

158
Active Trials
51
Phase 1
50
Phase 2
73
Phase 3
14
Therapeutic Areas
Portfolio Concentration: 72% of active trials in Oncology

Gastrointestinal

7 active / 12 total

Musculoskeletal

0 active / 6 total

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)